3-quinuclidinyl-4-iodobenzilate has been researched along with piperidines in 1 studies
| Studies (3-quinuclidinyl-4-iodobenzilate) | Trials (3-quinuclidinyl-4-iodobenzilate) | Recent Studies (post-2010) (3-quinuclidinyl-4-iodobenzilate) | Studies (piperidines) | Trials (piperidines) | Recent Studies (post-2010) (piperidines) |
|---|---|---|---|---|---|
| 37 | 4 | 0 | 40,235 | 5,221 | 14,545 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Brown, D; Chisholm, JA; Owens, J; Patterson, J; Pimlott, S; Wyper, D | 1 |
1 trial(s) available for 3-quinuclidinyl-4-iodobenzilate and piperidines
| Article | Year |
|---|---|
Acetylcholine muscarinic receptors and response to anti-cholinesterase therapy in patients with Alzheimer's disease.
Topics: Aged; Aged, 80 and over; Alzheimer Disease; Brain; Cerebrovascular Circulation; Cholinesterase Inhibitors; Donepezil; Female; Humans; Indans; Male; Middle Aged; Piperidines; Psychiatric Status Rating Scales; Quinuclidinyl Benzilate; Radionuclide Imaging; Radiopharmaceuticals; Receptor, Muscarinic M1; Receptors, Muscarinic; Reproducibility of Results; Sensitivity and Specificity; Statistics as Topic; Technetium Tc 99m Exametazime; Tissue Distribution; Treatment Outcome | 2003 |